Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

총 49 건의 최근 내부자 거래 내역가 기록되었습니다 Vallon Pharmaceuticals, Inc. (VLON), 포함 30 건 매수 및 8 건 매도. 내부자 매수 총액은 $3M 내부자 매도 총액은 $254.48K.

최근 활동이 있는 주요 내부자에는 Kelly Leanne, Szekeres David Leslie, Rongen Roelof. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — VLON

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2023-09-22	Kelly Leanne	Chief Financial Officer	RSU 부여	83,333	$1.52	$126.67K	83,333
2023-08-10	Szekeres David Leslie	Director	RSU 부여	34,483	$2.90	$100K	34,483
2023-08-10	Rongen Roelof	Director	RSU 부여	34,483	$2.90	$100K	34,483
2023-08-10	Simpson Camilla V	Director	RSU 부여	34,483	$2.90	$100K	34,483
2023-08-10	Baker David Charles	Director	RSU 부여	34,483	$2.90	$100K	34,483
2023-04-21	Szekeres David Leslie	Director	알 수 없음	-	-	-	-
2023-04-21	Agro Albert	Chief Medical Officer	RSU 부여	172,189	-	-	172,189
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	RSU 부여	385,510	-	-	385,510
2023-04-21	Chaturvedi Vipin	Chief Scientific Officer	RSU 부여	172,189	-	-	172,189
2023-04-21	Agro Albert	Officer	알 수 없음	-	-	-	-
2023-04-21	Rongen Roelof	Director	알 수 없음	-	-	-	-
2023-04-21	Simpson Camilla V	Director	알 수 없음	-	-	-	-
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	알 수 없음	-	-	-	-
2023-04-21	Chaturvedi Vipin	Officer	알 수 없음	-	-	-	-
2022-12-13	Thorell Marella	Director	기타 (매도)	28,517	-	-	9,506
2022-07-01	Thorell Marella	Director	RSU 부여	38,023	-	-	38,023
2022-06-09	Payne Joseph E	Director	RSU 부여	7,500	-	-	7,500
2022-06-09	Thorell Marella	Director	RSU 부여	7,500	$0.51	$3.83K	7,500
2022-06-09	Ammer Richard	Director	RSU 부여	7,500	-	-	7,500
2022-02-23	Chhabra Meenu	Director	알 수 없음	-	-	-	-
2022-02-23	Chhabra Meenu	Director	RSU 부여	15,000	$7.67	$115.05K	15,000
2022-02-15	Kelly Leanne M.	Chief Financial Officer	RSU 부여	50,000	$5.63	$281.5K	50,000
2022-02-15	Baker David Charles	Chief Executive Officer	RSU 부여	61,000	$5.63	$343.43K	61,000
2021-06-04	Kelly Leanne M.	Chief Financial Officer	정보 매수	1,508	$4.08	$6.15K	6,250
2021-06-03	Kelly Leanne M.	Chief Financial Officer	정보 매수	1,085	$4.05	$4.39K	4,742
2021-06-02	Kelly Leanne M.	Chief Financial Officer	정보 매수	3,657	$4.00	$14.63K	3,657
2021-05-26	Payne Joseph E	Director	정보 매수	6,800	$4.50	$30.6K	17,500
2021-05-25	Payne Joseph E	Director	정보 매수	10,700	$3.85	$41.2K	10,700
2021-05-14	Kelly Leanne M.	Chief Financial Officer	RSU 부여	70,000	$3.66	$256.2K	70,000
2021-05-14	Payne Joseph E	Director	RSU 부여	14,286	$3.66	$52.29K	14,286
2021-05-14	Toren Penny	SVP, Regul Affairs & Prog Mgmt	RSU 부여	25,000	$3.66	$91.5K	25,000
2021-05-14	Levi Ofir	Director	RSU 부여	15,000	$3.66	$54.9K	15,000
2021-05-14	Ammer Richard	Director	RSU 부여	10,204	$3.66	$37.35K	10,204
2021-05-14	Baker David Charles	Chief Executive Officer	RSU 부여	100,000	$3.66	$366K	100,000
2021-05-11	Kelly Leanne M.	Officer	알 수 없음	-	-	-	-
2021-02-12	Thorell Marella	Director	RSU 부여	15,000	$8.00	$120K	15,000
2021-02-12	Ammer Richard	Director	기타 (매수)	47,063	$6.40	$301.2K	47,063
2021-02-12	Salmon Pharma Gmbh	10 Percent Owner	기타 (매수)	47,063	$6.40	$301.2K	47,063
2021-02-12	Baker David Charles	Chief Executive Officer	기타 (매수)	7,843	$6.40	$50.2K	7,843
2021-02-09	Thorell Marella	Director	알 수 없음	-	-	-	-
2021-02-09	Toren Penny	SVP, Regul Affairs & Prog Mgmt	처분	5,000	$3.82	$19.1K	-
2021-02-09	Levi Ofir	Director	처분	-	-	-	196,875
2021-02-09	Ammer Richard	10 Percent Owner	알 수 없음	-	-	-	1,476,734
2021-02-09	Salmon Pharma Gmbh	10 Percent Owner	처분	-	-	-	1,476,734
2021-02-09	Payne Joseph E	10 Percent Owner	알 수 없음	-	-	-	843,750
2021-02-09	Arcturus Therapeutics Holdings Inc.	10 Percent Owner	처분	-	-	-	843,750
2021-02-04	Baker David Charles	Chief Executive Officer	처분	61,250	$2.20	$134.75K	-
2019-01-15	Baker David Charles	Chief Executive Officer	처분	46,875	$1.84	$86.25K	-
2018-10-01	Toren Penny	SVP, Regul Affairs & Prog Mgmt	처분	7,813	$1.84	$14.38K	-